Literature DB >> 11698649

Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin.

M Kokaia1, K Holmberg, A Nanobashvili, Z Q Xu, Z Kokaia, U Lendahl, S Hilke, E Theodorsson, U Kahl, T Bartfai, O Lindvall, T Hökfelt.   

Abstract

The neuropeptide galanin has been shown to suppress epileptic seizures. In cortical and hippocampal areas, galanin is normally mainly expressed in noradrenergic afferents. We have generated a mouse overexpressing galanin in neurons under the platelet-derived growth factor B promoter. RIA and HPLC analysis revealed up to 8-fold higher levels of galanin in transgenic as compared with wild-type mice. Ectopic galanin overexpression was detected especially in dentate granule cells and hippocampal and cortical pyramidal neurons. Galanin-overexpressing mice showed retardation of seizure generalization during hippocampal kindling, a model for human complex partial epilepsy. The high levels of galanin in mossy fibers found in the transgenic mice were further increased after seizures. Frequency facilitation of field excitatory postsynaptic potentials, a form of short-term synaptic plasticity assessed in hippocampal slices, was reduced in mossy fiber-CA3 cell synapses of galanin-overexpressing mice, indicating suppressed glutamate release. This effect was reversed by application of the putative galanin receptor antagonist M35. These data provide evidence that ectopically overexpressed galanin can be released and dampen the development of epilepsy by means of receptor-mediated action, at least partly by reducing glutamate release from mossy fibers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698649      PMCID: PMC61157          DOI: 10.1073/pnas.231496298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

Authors:  R A Steiner; J G Hohmann; A Holmes; C C Wrenn; G Cadd; A Juréus; D K Clifton; M Luo; M Gutshall; S Y Ma; E J Mufson; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Immunohistochemical mapping of galanin-like neurons in the rat central nervous system.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Peptides       Date:  1985 May-Jun       Impact factor: 3.750

3.  Galanin-like immunoreactivity in hippocampal afferents in the rat, with special reference to cholinergic and noradrenergic inputs.

Authors:  T Melander; W A Staines; A Rökaeus
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

4.  Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Peptides       Date:  1986 Jul-Aug       Impact factor: 3.750

5.  Distribution of galaninlike immunoreactivity in the rat central nervous system.

Authors:  T Melander; T Hökfelt; A Rökaeus
Journal:  J Comp Neurol       Date:  1986-06-22       Impact factor: 3.215

6.  Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.

Authors:  K E Smith; C Forray; M W Walker; K A Jones; J A Tamm; J Bard; T A Branchek; D L Linemeyer; C Gerald
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

7.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

8.  Galanin - a novel biologically active peptide from porcine intestine.

Authors:  K Tatemoto; A Rökaeus; H Jörnvall; T J McDonald; V Mutt
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

9.  The organization of projections from the olfactory bulb to the piriform cortex and olfactory tubercle in the rat.

Authors:  J W Scott; R L McBride; S P Schneider
Journal:  J Comp Neurol       Date:  1980-12-01       Impact factor: 3.215

10.  Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis.

Authors:  T Collins; D Ginsburg; J M Boss; S H Orkin; J S Pober
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

View more
  27 in total

1.  Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.

Authors:  Takashi Yoshitake; Fu-Hua Wang; Eugenia Kuteeva; Kristina Holmberg; Masatoshi Yamaguchi; Jacqueline N Crawley; Robert Steiner; Tamas Bartfai; Sven Ove Ogren; Tomas Hökfelt; Jan Kehr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-30       Impact factor: 11.205

2.  Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.

Authors:  Tamas Bartfai; Xiaoying Lu; Hedieh Badie-Mahdavi; Alasdair M Barr; Andrey Mazarati; Xiao-Ying Hua; Tony Yaksh; Gebhard Haberhauer; Susana Conde Ceide; Laurent Trembleau; Laszlo Somogyi; Lenz Kröck; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 3.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

4.  Gene therapy in epilepsy.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

5.  Histaminergic neurons protect the developing hippocampus from kainic acid-induced neuronal damage in an organotypic coculture system.

Authors:  Tiina-Kaisa Kukko-Lukjanov; Sanna Soini; Tomi Taira; Kimmo A Michelsen; Pertti Panula; Irma E Holopainen
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

6.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

7.  In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures.

Authors:  Andrey M Mazarati; Roger A Baldwin; Steve Shinmei; Raman Sankar
Journal:  J Neurochem       Date:  2005-10-07       Impact factor: 5.372

8.  Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling.

Authors:  Raman Sankar; Stéphane Auvin; Young Se Kwon; Eduardo Pineda; Don Shin; Andréy Mazarati
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

Review 9.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

10.  Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Authors:  A Mazarati; X Lu; S Shinmei; H Badie-Mahdavi; T Bartfai
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.